Juliette Cubanski, Ph.D., MPP, MPH, is the deputy director of the Program on Medicare Policy at KFF (Kaiser Family Foundation), where she has been conducting data-driven analysis focused on Medicare for more than 15 years. Dr. Cubanski leads KFF’s analysis of Medicare prescription drug coverage and related policy issues, including trends in the Medicare Part D drug benefit program. Her other areas of focus include Medicare spending and financing; coverage, cost, and access issues; the financial burden of health care spending among Medicare beneficiaries; and policy proposals related to Medicare reform. Dr. Cubanski earned a Ph.D. in health policy at Harvard University, a Masters of Public Policy and a Masters of Public Health from the University of California, Berkeley, and a Bachelor of Arts degree from the University of California at Los Angeles.
Stacie B. Dusetzina, Ph.D., is an associate professor in the Department of Health Policy and an Ingram associate professor of cancer research at Vanderbilt University School of Medicine. She is a health services researcher whose work focuses on measuring and evaluating population-level use and costs of medications in the United States. Dr. Dusetzina’s work has contributed to the evidence base for the role of drug costs on patient access to care and policy changes that might improve patient access to high-priced drugs. She has been recognized for her work at a national level, including being an invited participant for two working group meetings on “Patient Access to Affordable Cancer Drugs,” hosted by the President’s Cancer Panel, and being selected to co-author a National Academies of Sciences, Engineering and Medicine report on the same topic.
Leigh Purvis, MPH, is the director of Health Care Costs and Access in AARP’s Public Policy Institute. She leads a team of policy analysts and researchers who work on health care issues that are relevant to the 50+ population. In addition, Ms. Purvis heads the Institute’s work on prescription drugs. Her primary areas of expertise are prescription drug pricing, biologic drugs, and prescription drug coverage under Medicare. She is a co-author of the Public Policy Institute’s annual Rx Price Watch reports, which track price trends for prescription drugs widely used by older Americans. Ms. Purvis joined AARP in 2005 as a senior policy research analyst. Prior to her tenure at AARP, she worked for the American Psychological Association. Ms. Purvis is a recognized expert on prescription drug issues and frequently speaks with the press. Ms. Purvis has a MPA with a concentration in health administration and policy from George Mason University and a BS in psychology from the University of Mary Washington. She also holds a certificate in gerontology from the University of Washington.
Return to event page »